TUBE, DRAINAGE, SURGI

GF HEALTH PRODUCTS, INC. (CAGE 3HE02) has been awarded a fixed-price contract under solicitation SPE2DS-26-T-247C for the supply of surgical drainage tubes, identified by NSN 6515016883476, with two line items totaling 12 boxes—11 boxes of 25 units each and one additional box—delivered to Scholfield Barracks, HI, and Humphreys Pyeongtaek, KR. The contract, awarded on July 23, 2026, carries a total value of $314.28, though unit and extended prices are not listed in the documentation. Performance is governed by strict packaging and marking standards, with Medical Marking Standard No. 1 (MMS No. 1) mandating labeling including NSN, lot number, expiration date, and barcoding, superseding MIL-STD-129 for medical items; packaging must meet MIL-STD-2073-1E and DLA’s RP001, requiring sealed unit containers and commercial shipping packaging with palletization as specified. The products must be made of natural rubber (latex), be protein-free, seamless, translucent, and sterilizable. Inspection and acceptance occur at the destination, with the contractor responsible for compliance with all delivery, marking, and documentation requirements prior to shipment. The contractor must comply with extensive regulatory clauses related to cybersecurity, including NIST SP 800-171 and safeguarding covered defense information, trafficking in persons, employment eligibility verification, sustainable products, and hazardous material identification with submission of Safety Data Sheets per 29 CFR 1910.1200. Special provisions mandate disclosure of joint venture partners’ UEI and CAGE codes, compliance with DEVIATION 2026-00038 for multiple clauses, and adherence to the prohibition on acquiring covered defense telecommunications equipment. Payment must be submitted via Wide Area WorkFlow (WAWF), and the contract incorporates clauses for changes, subcontracting commercial products, accelerated payments to small business subcontractors, and unenforceability of unauthorized obligations. The contracting officer and contracting officer’s representative details are not disclosed, and no evaluation factors, contract type, or option periods are explicitly defined. All submissions were required through DIBBS with a deadline of July 27, 2026, and the award reflects a